Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-23-008873
Filing Date
2023-03-31
Accepted
2023-03-31 17:13:16
Documents
5
Effectiveness Date
2023-03-31
Reference 429
333-264953

Document Format Files

Seq Description Document Type Size
1 FORM S-8 nby20230328_s8.htm S-8 76598
2 EXHIBIT 5.1 ex_494384.htm EX-5.1 11101
3 EXHIBIT 23.1 ex_495178.htm EX-23.1 3145
4 EXHIBIT FILING FEES ex_494385.htm EX-FILING FEES 14088
5 spblogo.jpg GRAPHIC 4350
  Complete submission text file 0001437749-23-008873.txt   112181
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271053 | Film No.: 23789114
SIC: 2834 Pharmaceutical Preparations